BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24621346)

  • 1. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.
    Scher RK; Nakamura N; Tavakkol A
    Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
    Shimamura T; Hasegawa N; Kubota N
    Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Kishida H; Okubo A
    J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
    Kawai M
    Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution of Luliconazole in Nail Plate by In Vitro Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution].
    Shimamura T; Miyamae A; Arai M; Minemura A; Nozawa A; Kubota N
    Med Mycol J; 2016; 57(1):J19-25. PubMed ID: 26936348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.
    Bristow I; Baran R; Score M
    J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
    Shimamura T; Miyamae A; Imai A; Hirayanagi K; Iwanaga T; Kubota N; Shibuya K
    Med Mycol J; 2016; 57(4):J141-J147. PubMed ID: 27904059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
    Bohn M; Kraemer KT
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tavaborole topical solution (Kerydin) for onychomycosis.
    Med Lett Drugs Ther; 2015 Mar; 57(1463):35-6. PubMed ID: 25719999
    [No Abstract]   [Full Text] [Related]  

  • 13. Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
    Zane LT; Plattner J; Chanda S; Coronado D; Merchant T; Alley MR; Gupta AK
    Drugs Today (Barc); 2015 Oct; 51(10):599-607. PubMed ID: 26583302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis: rationalization of topical treatment.
    Shemer A; Trau H; Davidovici B; Amichai B; Grunwald MH
    Isr Med Assoc J; 2008 Jun; 10(6):415-6. PubMed ID: 18669135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Topical Antifungal Luliconazole on Hyphal Morphology of Trichophyton mentagrophytes Grown on in vitro Onychomycosis Model.
    Nishiyama Y; Maeda M; Yamada T
    Mycopathologia; 2022 Dec; 187(5-6):491-496. PubMed ID: 36057744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tavaborole - a treatment for onychomycosis of the toenails.
    Gupta AK; Versteeg SG
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of onychomycosis.
    Urrutia N; Port M; Bergen G; Bernard J
    Clin Podiatr Med Surg; 1995 Apr; 12(2):249-53. PubMed ID: 7600498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.